In the majority of studies, correlations of CD68 expression with the following clinicopathological parameters, histological grade, tumor size, TNM stage, lymph node status, and lymphovascular invasion, as well as with distant metastasis, recurrence and survival rates, were analyzed [9, 17]. The gene discussed is CD68; the disease is neoplasm.